Plenary Session 3: Translating pharmacoepidemiology research into real-world practice in the Asia-Pacific region
| Monday, October 14, 2024 |
| 10:15 - 11:15 |
| Yasuda Auditorium |
Speaker
Prof. Yea-Huei Kao
School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Science, College of Medicine, National Cheng Kung
Keynote speaker: Translating pharmacoepidemiology research into real-world practice in the Asia-Pacific region
Abstract
This keynote session celebrates the lifelong achievements of Dr. Yeahuei Kao Yang in building and promoting pharmacoepidemiology programs in Taiwan and across the Asia-Pacific region. Dr. Yang’s contributions have been instrumental in fostering the next generation of researchers who generate pharmacoepidemiology evidence, as well as those who translate this evidence into clinical practice.
In recent years, the integration of real-world evidence (RWE) from pharmacoepidemiology research has become essential to regulatory decisions, including drug approvals, new indications, and drug safety monitoring. Regulatory agencies have encouraged these practices through official guidelines, primarily targeting industry stakeholders.
Moreover, RWE from pharmacoepidemiology and findings from clinical trials are increasingly incorporated into package inserts, prescribing information, and clinical guidelines endorsed by medical societies. These materials, aimed at clinical practitioners such as physicians and pharmacists, are intended to promote the safer and more effective use of medications.
In honor of Dr. Yang’s vision, this keynote session will hear Dr. Kao-Yang’s vision and achievement and the panel will reflect from multidisciplinary perspectives to enhance medication safety and efficacy in the Asia-Pacific region by bridging research and clinical practice.
In recent years, the integration of real-world evidence (RWE) from pharmacoepidemiology research has become essential to regulatory decisions, including drug approvals, new indications, and drug safety monitoring. Regulatory agencies have encouraged these practices through official guidelines, primarily targeting industry stakeholders.
Moreover, RWE from pharmacoepidemiology and findings from clinical trials are increasingly incorporated into package inserts, prescribing information, and clinical guidelines endorsed by medical societies. These materials, aimed at clinical practitioners such as physicians and pharmacists, are intended to promote the safer and more effective use of medications.
In honor of Dr. Yang’s vision, this keynote session will hear Dr. Kao-Yang’s vision and achievement and the panel will reflect from multidisciplinary perspectives to enhance medication safety and efficacy in the Asia-Pacific region by bridging research and clinical practice.
Biography
Yea-Huei, is now the Professor Emeritus of the School of Pharmacy, and the Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University (NCKU), Taiwan, after retiring from Feb 2024. She is one of the leading pioneers in promoting education on clinical pharmacy and pharmacoepidemiology research in Taiwan. She has been actively involved in regulatory affairs by serving as an expert member in various advisory committees in the Ministry of Health and Welfare and Ministry of Education.
Yea-Huei established the first-ever graduate program of clinical pharmacy with Master degree and pharmacoepidemiology program with PhD in NCKU. That has contributed to cultivate pharmacy scientist in Taiwan. Also, she organized the Center of Health Outcome Research to promote leveraging population data for real world evidence, which has informed regulatory decision in Taiwan.
She has joined the International Society of Pharmacoepidemiology since 1996 and has been awarded the Fellowship since 2012. Additionally, she has served as an Associate Editor for Pharmacoepidemiology and Drug Safety, the official journal of ISPE. She is one of the founding members of the Asia Pharmacoepidemiology Network. She hosted the 4th and 14thAsian Conference for Pharmacoepidemiology in Tainan, Taiwan, in 2009 and 2022, respectively, and the 30th Annual Conference of ISPE in Taipei in 2014.
Moderator
Frank May
RGH Pharmacy Consulting Services
Panelist
Ching-Lan Cheng
National Chen Kung Uiversity
Nam-Kyong Choi
ISPE committee member
EWHA WOMANS UNIVERSITY
Yagi Tatsuya
Hamamatsu University School of Medicine
